Apr 12, 2020
1:20
For every 20 shares held, investors received 1.
The split itself did not change the total investment value.
NEXTAGE Therapeutics Ltd. (TASE:NXTG) operates in the Pharmaceuticals: other industry.
NEXTAGE Therapeutics Ltd. company overviewNEXTAGE Therapeutics Ltd.'s most recent stock split was on April 12, 2020. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
NEXTAGE Therapeutics Ltd. (TASE:NXTG) has split its stock 3 times: a 10-for-1 split on August 11, 2015, a 1-for-10 reverse split on November 8, 2015, and a 1-for-20 reverse split on April 12, 2020.
NEXTAGE Therapeutics Ltd. has split its stock 3 times. This history records 3 splits between August 11, 2015 and April 12, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In NEXTAGE Therapeutics Ltd.'s 1-for-20 reverse split on April 12, 2020, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
NEXTAGE Therapeutics Ltd. has not announced a new split in our records. Its most recent split was on April 12, 2020, 6 years ago. Companies announce splits in advance, and any new TASE:NXTG split will appear on this page.
Already premium?